跳至主要内容
临床试验/CTRI/2020/09/027526
CTRI/2020/09/027526尚未招募2 期

A prospective open labeled observational study to document the potential safety issues and prescription trends of selected Rasausadhiâ??s in CCRAS -OPDâ??s across India - Pharmaco-epidemiological Study

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients who have normal levels of liver and kidney function tests.
  • 2. Patients willing to participate in the study for a minimum period of 1week to a maximum of 6 weeks.

排除标准

  • 1. Presence of renal or hepatic dysfunction.
  • 2. Subjects who have a history of Cardiac Arrhythmia, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia, Carcinoma etc
  • 3. Subjects with uncontrolled Pulmonary Dysfunction (asthmatic and COPD patients) or other concurrent severe disease.
  • 4. Uncontrolled Diabetes Mellitus (HbA1C >8)
  • 5. Any concurrent condition (medical, social or behavioral) that, in the opinion of the research team, would preclude or confound acquisition or interpretation of data or delivery of care.
  • 6. Patient having the H/O intake of Rasaoushadhi in the past 6 weeks.

研究者

相似试验